Polaris AI Pharma Corp. (KOSDAQ:041910)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,580.00
+40.00 (0.53%)
At close: May 8, 2026
Market Cap99.76B +32.7%
Revenue (ttm)63.94B +8.7%
Net Income989.48M -92.8%
EPS84.72 -92.8%
Shares Out13.28M
PE Ratio88.65
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,632,793
Average Volume1,408,125
Open7,500.00
Previous Close7,540.00
Day's Range7,400.00 - 8,240.00
52-Week Range5,620.00 - 10,200.00
Beta0.54
RSI59.71
Earnings Daten/a

About Polaris AI Pharma

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 160
Stock Exchange KOSDAQ
Ticker Symbol 041910
Full Company Profile